Revised SPC: Granocyte (lenograstim) pre-filled syringe

SPC now highlights that cases of venous thromboembolism and arterial thromboembolism (such as myocardial infarction and cerebrovascular event) have been reported in donors treated with lenograstim. Close monitoring is now recommended in donors and patients with known risk factors

Source:

electronic Medicines compendium